Abstract
Astrocytes are the most abundant cells in the brain and play an important role in the homeostasis and maintenance of the brain. Furthermore, astrocytes play a key role in brain protection and in functional recovery from injuries. Impairment in astrocytes activity may promote neurodegeneration and, eventually, retraction of neuronal synapses, which leads to cognitive deficits found in neurodegenrative diseases, such as Alzheimers disease. Alzheimers disease (AD) is the most common type of dementia affecting more than 18 million people worldwide. The main cause of AD is generally attributed to the increased production and accumulation of amyloid-β (Aβ), in association with neurofibrillary tangle (NFT) formation. In AD patients brain, reactive astrocytes are integral components of neuritic plaques. Astrocytic activation seems to be particularly prominent around Aβ deposits both in the brain parenchyma and in the cerebrovasculature. Furthermore, recent evidence from AD patients suggests that pathological changes in the morphology of astrocyte occur prior to the appearance of Aβ plaques. The focus of this review is on astrocytic cells and their role in the progression of AD.
Keywords: Astrocyte, Alzheimer's disease, imflammation, neuroprotection, homeostasis, brain protection, amyloid-β, astrogliosis, astrocyte atrophy, neuroinflammation
Current Signal Transduction Therapy
Title: Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Volume: 7 Issue: 1
Author(s): Tal Iram and Dan Frenkel
Affiliation:
Keywords: Astrocyte, Alzheimer's disease, imflammation, neuroprotection, homeostasis, brain protection, amyloid-β, astrogliosis, astrocyte atrophy, neuroinflammation
Abstract: Astrocytes are the most abundant cells in the brain and play an important role in the homeostasis and maintenance of the brain. Furthermore, astrocytes play a key role in brain protection and in functional recovery from injuries. Impairment in astrocytes activity may promote neurodegeneration and, eventually, retraction of neuronal synapses, which leads to cognitive deficits found in neurodegenrative diseases, such as Alzheimers disease. Alzheimers disease (AD) is the most common type of dementia affecting more than 18 million people worldwide. The main cause of AD is generally attributed to the increased production and accumulation of amyloid-β (Aβ), in association with neurofibrillary tangle (NFT) formation. In AD patients brain, reactive astrocytes are integral components of neuritic plaques. Astrocytic activation seems to be particularly prominent around Aβ deposits both in the brain parenchyma and in the cerebrovasculature. Furthermore, recent evidence from AD patients suggests that pathological changes in the morphology of astrocyte occur prior to the appearance of Aβ plaques. The focus of this review is on astrocytic cells and their role in the progression of AD.
Export Options
About this article
Cite this article as:
Iram Tal and Frenkel Dan, Targeting the Role of Astrocytes in the Progression of Alzheimers Disease, Current Signal Transduction Therapy 2012; 7 (1) . https://dx.doi.org/10.2174/157436212799278232
DOI https://dx.doi.org/10.2174/157436212799278232 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Treatment of Atrial Fibrillation: Mechanisms of Action and Efficacy of Class III Drugs
Current Medicinal Chemistry Elucidating Treatment of Alzheimer's Disease via Different Receptors
Current Topics in Medicinal Chemistry Preservation of Cellular Glutathione Status and Mitochondrial Membrane Potential by N-Acetylcysteine and Insulin Sensitizers Prevent Carbonyl Stress-Induced Human Brain Endothelial Cell Apoptosis
Current Neurovascular Research Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Current Pharmaceutical Design Heightened Attention for Wnt Signaling in Diabetes Mellitus
Current Neurovascular Research Inappropriate Antidopaminergic Drug Use in Parkinson’s Disease Inpatients
Current Drug Therapy BioArena Studies: Unique Function of Endogenous Formaldehyde and Ozone in the Antibiotic Effect – A Review
Medicinal Chemistry Following Intracellular Cholesterol Transport by Linear and Non-Linear Optical Microscopy of Intrinsically Fluorescent Sterols
Current Pharmaceutical Biotechnology Modulatory Activity of Soluble Beta Amyloid on HPA Axis Function in Rats
Current Pharmaceutical Design Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People
Current Alzheimer Research 4-Acetamidobenzaldehyde Derivatives as Biological Active Candidates; Synthesis, Anti-oxidant, Anti-Alzheimer and DNA Binding Studies
Letters in Drug Design & Discovery Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations
Current Cardiology Reviews Possible Pathomechanisms Responsible for Injury to the Central Nervous System in the Settings of Chronic Cerebrospinal Venous Insufficiency
Reviews on Recent Clinical Trials Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry Chronic Stress Impacts on Olfactory System
CNS & Neurological Disorders - Drug Targets Complex Atheromatosis of the Aortic Arch in Cerebral Infarction
Current Cardiology Reviews Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease
Current Neuropharmacology Topical Discoveries on Multi-Target Approach to Manage Alzheimer’s Disease
Current Drug Metabolism The Impact of the Induction of Multidrug Resistance Transporters in Therapies by Used Drugs: Recent Studies
Mini-Reviews in Medicinal Chemistry